Showing results (131-140 of 232) with videos related to
Sort By:
Pageof 24
Journal of Neurology|November 14, 2019
Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison studyLuca Prosperini, Antonio Cortese, Matteo Lucchini, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|February 21, 2015
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroadsLuca Prosperini, Pietro Annovazzi, Marco Capobianco, et al.Journal of Neurology|October 17, 2025
Efficacy and safety of ublituximab for relapsing multiple sclerosis patients: current evidence and expert opinionPaolo Preziosa, Vincenzo Brescia Morra, Marco Capobianco, et al.European Journal of Neurology|March 31, 2021
Scoring the 10-year risk of ambulatory disability in multiple sclerosis: the RoAD scoreClaudio Gasperini, Luca Prosperini, Àlex Rovira, et al.Journal of Neurology|May 10, 2021
Machine learning classifier to identify clinical and radiological features relevant to disability progression in multiple sclerosisSilvia Tommasin, Sirio Cocozza, Alessandro Taloni, et al.Journal of the Neurological Sciences|March 4, 2026
Predictors of short-term, relapse-independent progression in multiple sclerosis: A machine learning approach based on clinical data and conventional MRI-derived featuresAntonio Ianniello, Elena Barbuti, Maria Francesca Capobianco, et al.Medicina (Kaunas, Lithuania)|March 29, 2023
Potential Protective Role of Pregnancy and Breastfeeding in Delaying Onset Symptoms Related to Multiple SclerosisAlessandra Logoteta, Maria Grazia Piccioni, Riccardo Nistri, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 29, 2025
Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched studyElena Barbuti, Alessia Castiello, Valeria Pozzilli, et al.Journal of Neurology|April 17, 2002
Monthly corticosteroids decrease neutralizing antibodies to IFNbeta1 b: a randomized trial in multiple sclerosisCarlo Pozzilli, Giovanni Antonini, Francesca Bagnato, et al.Biochimica Et Biophysica Acta|April 15, 2014
Serum lactate as a novel potential biomarker in multiple sclerosisAngela M Amorini, Viviana Nociti, Axel Petzold, et al.Pageof 24